Special issue: adenosine receptors

dc.contributor.authorCiruela Alférez, Francisco
dc.contributor.authorSotelo, Eddy
dc.date.accessioned2018-05-02T09:25:39Z
dc.date.available2018-05-02T09:25:39Z
dc.date.issued2017-07-20
dc.date.updated2018-05-02T09:25:39Z
dc.description.abstractNearly 90 years ago, Drury and Szent-Györgyi revealed that adenosine produced profound hypotension and bradycardia, and it affected kidney function in mammals [1]. Since then, the physiological role and potential therapeutic use of adenosine have been extensively explored [2,3]. Adenosine is considered a retaliatory metabolite [4], thus increasing oxygen supply and decreasing oxygen consumption.
dc.format.extent4 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec679444
dc.identifier.issn1420-3049
dc.identifier.pmid28726742
dc.identifier.urihttps://hdl.handle.net/2445/121982
dc.language.isoeng
dc.publisherMDPI
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/molecules22071220
dc.relation.ispartofMolecules, 2017, vol. 22, num. 7, p. 1220
dc.relation.urihttps://doi.org/10.3390/molecules22071220
dc.rightscc-by (c) Ciruela Alférez, Francisco et al., 2017
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject.classificationAdenosina
dc.subject.classificationReceptors neurals
dc.subject.classificationPurines
dc.subject.classificationBatecs cardíacs
dc.subject.otherAdenosine
dc.subject.otherNeural receptor
dc.subject.otherPurines
dc.subject.otherHeart beat
dc.titleSpecial issue: adenosine receptors
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
679444.pdf
Mida:
164.94 KB
Format:
Adobe Portable Document Format